数据集机会

Tolid — LLM 标注语料库:加密货币新闻、生物医学专利、美妆视频

一家销售其构建语料库并仍运营构建这些语料库的管道的公司。

LLM 标注语料库 / 知识图谱文本领域 LLM 训练、知识图谱、情绪模型🌍 Francetolid.io2026年7月15日

置信度

60%

市场

标注训练数据,其标签质量是可衡量的,而非断言的——几乎没有竞争性语料库能做出此声明。已声明其缺陷并提供生成它的管道作为服务进行销售。

Lineage

此线索的来源

信号优先链,端到端:近期外部信号 → 合格利基 → 已解析的数据持有者 → 网站验证 → 评分机会。每个线索都可解释。

Profile

数据集概况

类型

LLM 标注语料库 / 知识图谱

模态

文本

行业

AI 训练数据

体量

2.47M 文档 · 723k 专利 · 449 个流程

新鲜度

存档 — 管道可重启

稀有度

高 — 标注,而非文本

可访问性

即时 — BigQuery / Firestore 镜像

法律

标注、图谱和元数据是 Tolid 生成的衍生作品,可转移。源新闻文本不可转移(属于出版商)——不包含在任何交付内容中。BIOPORTAL — 已测量和解决(2026-07-14):使用了 707 个本体集,而非一个。来自限制性许可来源的 13,757 行(占映射表的 1.6%)—— SNOMED CT、MedDRA、RxNorm、OMIM、NDDF、Read Codes、ICD、CPT — 不包含在任何交付内容中。其他所有内容均按设计开放(OBO Foundry 要求其成员遵守 CC-BY/CC0;MeSH 可免费用于商业用途)。CC-BY 是署名义务,而非 copyleft:数据附带署名通知。仍未解决:Open Beauty Facts ODbL 状态(美妆语料库)——对抗性审查驳斥了“生成作品”的解读,因此该限制可能为二元而非价格折扣。四个生物识别推断列(感知性别、年龄范围、情绪、肤色)不包含在任何交付内容中。

买家画像

领域 LLM 和金融 NLP 模型出版商 · 制药和生物技术研发(专利情报) · 化妆品集团和美妆科技 · 希望训练自己分类器的供应商。不适用于对冲基金或加密货币语料库的信号供应商——它不产生阿尔法,我们已明确说明。

Tolid 是一家数据公司。它不转售他人的数据:它构建了生成这些语料库的集合和 LLM 标注管道,并且至今仍在运营它们。因此,本次提供的是两样东西——一批标注好的数据,以及生成它的机器

三份语料库可供选择。

1. 加密货币新闻,已标注(2,469,218 份文档,2023 年 10 月 → 2025 年 9 月)。 包含对标准化代币的情绪、主题、摘要和买入/持有/卖出标签。请务必先阅读此内容:交易信号不具备任何可测量的预测能力。 我们自己对所有 1,198,479 个信号进行了回测,与真实价格进行比较:其表现比抛硬币好 0.7 个点,并且其市场中性阿尔法为零。原因在于数据——新闻情绪与过去回报的相关性为 +0.60,与未来回报的相关性为 +0.07。它跟随价格;它并不领先。我们不销售阿尔法,此语料库不适用于交易部门。 同样是 +0.60 的相关性证明了标注的准确性:这是一个 LLM 标记的金融语料库,其标签质量已根据外部真实情况进行了验证。您购买的是这个——具有可衡量质量的训练数据,而不是信号。

2. 生物医学专利,结构化为知识图谱(723,149 份文档)。 三者中最有价值的资产,也是承载最大未决问题的资产:与其对齐的 BioPortal 本体集的许可条款正在审查中。我们会在您询问之前告知您。

3. 程序化美妆视频(449 个流程,7,656 个带时间戳的手势,21,441 个视频)。 不是“视频数据”:而是对人们实际操作的分析表面,一步一步地使用哪些产品。提前声明两个限制——Open Beauty Facts ODbL 问题尚未解决,可能为二元而非折扣,并且四个生物识别推断列(感知性别、年龄、情绪、肤色)不包含在任何交付内容中。程序化图谱在没有这些的情况下仍保留其全部价值。

我们不销售的内容:源文章文本。它属于出版商,不属于 Tolid。可转移的是衍生作品——标注、URL、元数据、图谱。

Services

持有者可为您提供的其他服务

此数据集不仅仅是数据资产 — 其持有者仍在运营生成它的数据管道。以下每项能力都基于观察到的事实,而非主张。

Human validation of the annotations, on demand

Tolid can run a human review pass over any corpus it has produced — full or sampled, to your own guidelines and quality bar.

证据The entire human-in-the-loop layer already exists — nine moderation tables, an escalation queue, prompt structures — and has never been run on a single document (0 of 4,841,938). The machine is built and wired; it has simply never been switched on.

A corpus built to your theme, from scratch

Give a domain and a taxonomy; Tolid runs collection, LLM annotation and graph construction end-to-end — the same pipeline that produced these corpora.

证据The pipeline is theme-driven, and there is proof: a seventh theme ("Geopolitical Tensions and Alliances") is fully configured — prompt and JSON template written — with no collection and no deployed service. A theme conceived, written, never launched. That is what "give us a subject" looks like in this codebase.

Entity resolution and normalisation

Mapping the messy surface forms of a domain onto canonical entities — the unglamorous work that decides whether a corpus is joinable with your own data.

证据21,359 alias → canonical-ticker mappings were built for the crypto corpus; 19,080 semantic mappings for the beauty ontology. This is the domain's price of entry, already paid.

Cleaning and extending an existing signal

Re-parsing, de-duplicating and extending a field that was produced once and never curated.

证据Declared openly: the buy/hold/sell field covers only ~44% of the crypto rows and carries parsing leaks (`buy (implied)`, `hold/sell`). Tolid can clean and extend it. We would rather sell you the fix than hide the defect.

Scoring

评分维度

可解释的、基于证据的维度(0-100)。雷达图显示了投资轴。

-

查看维度详情
SpecificityRarityVolumeTraining ValueBuyer DemandEvidence StrengthData Orientation

Evidence

数据集证据与溯源

类型化证据证明公司持有的内容 — 为清晰起见重新表述并与市场对比。

-

Marketplace

数据集详情

地理覆盖范围

Global (multilingual sources)

时间范围

2023-10 → 2025-09 (crypto) · patents and beauty: see each dataset

交付方式

Secure extract download, or scoped access

格式

parquet, csv, jsonl

许可

Derived works (annotations, graphs, metadata) are transferable. Source press text is not.

个人数据

不含个人数据

· licence· 最终价格需询价

There is no public price grid for these corpora, and we will not manufacture one. Our own valuation engine returns wide, UNANCHORED ranges — dispersion up to ×7 on the crypto asset across three identical runs — and a dedicated deep-research study (July 2026, 103 agents, 86 claims → 25 adversarially verified) confirmed WHY: for an LLM-annotated news archive sold as annotations-only, no defensible market comparable exists. The published editor↔LLM deals disclose amounts but never volumes, so no per-document price can be derived; and the closest academic comparable (Financial PhraseBank) anchors label PEDIGREE, never a number. The gap is in the market, not in our research. So we price ON REQUEST, against two things we can defend: a measured production cost (from real cloud billing) and a label quality validated against external ground truth. The biomedical-patents asset — the strongest of the three — is under its own valuation study; its price will be shown only once anchored on real dataset transactions, never on a SaaS-subscription proxy. You do not buy the bundle: each dataset is priced on its own.

详细数据结构和样本可在申请访问后查看。

想要这份数据?

请求访问权限——我们提供安全的交易室。经运营方审核,不会自动共享。

分享此机会

此列表是根据公开信号自动生成的。它未经核实,我们与该公司无任何关联。

Deal room

Tolid — LLM-annotated corpora: crypto news, biomedical patents, beauty video

status: broker_protected

There is no public price grid for these corpora, and we will not manufacture one. Our own valuation engine returns wide, UNANCHORED ranges — dispersion up to ×7 on the crypto asset across three identical runs — and a dedicated deep-research study (July 2026, 103 agents, 86 claims → 25 adversarially verified) confirmed WHY: for an LLM-annotated news archive sold as annotations-only, no defensible market comparable exists. The published editor↔LLM deals disclose amounts but never volumes, so no per-document price can be derived; and the closest academic comparable (Financial PhraseBank) anchors label PEDIGREE, never a number. The gap is in the market, not in our research. So we price ON REQUEST, against two things we can defend: a measured production cost (from real cloud billing) and a label quality validated against external ground truth. The biomedical-patents asset — the strongest of the three — is under its own valuation study; its price will be shown only once anchored on real dataset transactions, never on a SaaS-subscription proxy. You do not buy the bundle: each dataset is priced on its own.

Coverage

Scanned sources

https://tolid.iodiscovered

Deliverable

Premium dataset report

A teaser is generated for each dataset opportunity. The full report is available on unlock.

Teaser is public · premium is locked behind access.

市场精选

探索实时数据商机

按行业和用例浏览数据集
Tolid — LLM 标注语料库:加密货币新闻、生物医学专利、美妆视频 | d-nvest